Vistagen Therapeutics, Inc.
VTGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411685
No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Vistagen Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 106
- +1 vs. Q3 2021
- Shares held
- 138.2M
- +6.73M (+5.1%) vs. Q3 2021
- Total value
- $269.2M
- −$91.0M (−25.3%) vs. Q3 2021
- New holders
- 12
- 40 more added
- Sold out
- 11
- 29 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 48 | $2.54M |
| Q1 2026 | 56 | $8.12M |
| Q4 2025 | 55 | $8.84M |
| Q3 2025 | 58 | $81.8M |
| Q2 2025 | 51 | $30.3M |
| Q1 2025 | 48 | $39.0M |
| Q4 2024 | 54 | $44.9M |
| Q3 2024 | 47 | $45.3M |
| Q2 2024 | 43 | $56.3M |
| Q1 2024 | 42 | $90.8M |
| Q4 2023 | 46 | $90.0M |
| Q3 2023 | 34 | $15.7M |
| Q2 2023 | 33 | $1.82M |
| Q1 2023 | 83 | $4.79M |
| Q4 2022 | 86 | $4.15M |
| Q3 2022 | 93 | $9.13M |
| Q2 2022 | 112 | $122.1M |
| Q1 2022 | 116 | $167.8M |
| Q4 2021 | 106 | $269.2M |
| Q3 2021 | 105 | $360.2M |
| Q2 2021 | 101 | $389.0M |
| Q1 2021 | 74 | $225.2M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Vistagen Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Franklin Resources Inc | 10,117,999 | $19.7M | 0.01% | −4380.0% | Reduced |
| Acuta Capital Partners, LLC | 11,736,283 | $22.9M | 9.62% | +8,250+0.1% | Added |
| BlackRock Inc. | 11,894,193 | $23.2M | 0.00% | +145,721+1.2% | Added |
| OrbiMed Advisors LLC | 12,909,283 | $25.2M | 0.33% | 00.0% | Unchanged |
| VR Adviser, LLC | 16,047,286 | $31.3M | 4.28% | 00.0% | Unchanged |
| NEA Management Company, LLC | 16,302,596 | $31.8M | 0.64% | 00.0% | Unchanged |
| EAM Investors, LLC | 0 | $0 | 0.00% | −842,545−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −795,720−100.0% | Sold out |
| EAM Global Investors LLC | 0 | $0 | 0.00% | −634,743−100.0% | Sold out |
| Exencial Wealth Advisors, LLC | 0 | $0 | 0.00% | −98,731−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −33,434−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −31,984−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −14,800−100.0% | Sold out |
| Centaurus Financial, Inc. | 0 | $0 | 0.00% | −10,115−100.0% | Sold out |
| Koshinski Asset Management, Inc. | 0 | $0 | 0.00% | −3,600−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Gerber Kawasaki Wealth & Investment Management | 0 | $0 | 0.00% | −144−100.0% | Sold out |